Japan Airlines Reports Profit For 9-month Period, Cuts FY22 Guidance

Japan Airlines Corp.(JAPSY.OB), a Japanese group of airline companies, on Thursday reported a turnaround to profit for the nine-month period to December 31, 2022, amidst a rise in revenue, driven by an increased passenger demand. In addition, the company has revised down its full-year forecast.

For the nine-month period, the Japanese firm reported a profit of 16.3 billion yen, compared with a loss of 128.3 billion yen posted for the same period of previous year. EBIT was at 34.7 billion yen as against a loss of183.3 billion yen of previous year.

Operating expenses rose to 990.1 billion yen from last year's 687.9 billion yen.

The Group generated revenue of 1.005 trillion yen, compared with 498.4 billion yen of last year period.

Looking ahead, for the fiscal 2022, the company has revised down its guidance to reflect the recent trend in air transport demand.

For the full-year, the profit outlook has been revised to 25 billion yen, a decrease of 20 billion yen from the previous forecast.

Full-year EBIT guidance has been decreased to 50 billion yen, a reduction of 30 billion yen from the previous guidance.

The Group has also slashed revenue guidance to 1 trillion yen-358.0 billion yen, a decrease of 46 billion yen from the previous forecast.

The company expects to pay year-end per share dividend of 20 yen.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT